IRIS Accounts Production v26.1.10.61 10404648 director 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104046482025-03-31104046482026-03-31104046482025-04-012026-03-31104046482024-03-31104046482024-04-012025-03-31104046482025-03-3110404648ns15:EnglandWales2025-04-012026-03-3110404648ns14:PoundSterling2025-04-012026-03-3110404648ns10:Director12025-04-012026-03-3110404648ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3110404648ns10:SmallEntities2025-04-012026-03-3110404648ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3110404648ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3110404648ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3110404648ns10:FullAccounts2025-04-012026-03-3110404648ns10:OrdinaryShareClass12025-04-012026-03-3110404648ns10:OrdinaryShareClass22025-04-012026-03-3110404648ns10:RegisteredOffice2025-04-012026-03-3110404648ns5:CurrentFinancialInstruments2026-03-3110404648ns5:CurrentFinancialInstruments2025-03-3110404648ns5:Non-currentFinancialInstruments2026-03-3110404648ns5:Non-currentFinancialInstruments2025-03-3110404648ns5:ShareCapital2026-03-3110404648ns5:ShareCapital2025-03-3110404648ns5:RetainedEarningsAccumulatedLosses2026-03-3110404648ns5:RetainedEarningsAccumulatedLosses2025-03-311040464812025-04-012026-03-3110404648ns5:FurnitureFittings2025-04-012026-03-3110404648ns5:ComputerEquipment2025-04-012026-03-3110404648ns5:FurnitureFittings2025-03-3110404648ns5:ComputerEquipment2025-03-3110404648ns5:FurnitureFittings2026-03-3110404648ns5:ComputerEquipment2026-03-3110404648ns5:FurnitureFittings2025-03-3110404648ns5:ComputerEquipment2025-03-3110404648ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2026-03-3110404648ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-03-3110404648ns10:OrdinaryShareClass12026-03-3110404648ns10:OrdinaryShareClass22026-03-3110404648ns5:RetainedEarningsAccumulatedLosses2025-03-3110404648ns5:RetainedEarningsAccumulatedLosses2025-04-012026-03-311040464812025-04-012026-03-31
REGISTERED NUMBER: 10404648 (England and Wales)







Unaudited Financial Statements for the Year Ended 31st March 2026

for

Prident Dental Laboratory Limited

Prident Dental Laboratory Limited (Registered number: 10404648)






Contents of the Financial Statements
for the Year Ended 31st March 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Prident Dental Laboratory Limited

Company Information
for the Year Ended 31st March 2026







DIRECTOR: Mr M Soltani





REGISTERED OFFICE: 46 The Green
Morden
Surrey
Surrey
SM4 4HL





REGISTERED NUMBER: 10404648 (England and Wales)





ACCOUNTANTS: Dunkley's
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
United Kingdom
BS32 4JY

Prident Dental Laboratory Limited (Registered number: 10404648)

Balance Sheet
31st March 2026

31.3.26 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 7,430 8,742

CURRENT ASSETS
Debtors 5 14,419 8,044
Cash at bank 23,019 26,808
37,438 34,852
CREDITORS
Amounts falling due within one year 6 9,612 11,252
NET CURRENT ASSETS 27,826 23,600
TOTAL ASSETS LESS CURRENT LIABILITIES 35,256 32,342

CREDITORS
Amounts falling due after more than one year 7 - (844 )

PROVISIONS FOR LIABILITIES (1,412 ) (1,661 )
NET ASSETS 33,844 29,837

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 11 33,744 29,737
SHAREHOLDERS' FUNDS 33,844 29,837

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 28th May 2026 and were signed by:




Mr M Soltani - Director


Prident Dental Laboratory Limited (Registered number: 10404648)

Notes to the Financial Statements
for the Year Ended 31st March 2026

1. STATUTORY INFORMATION

Prident Dental Laboratory Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in Pounds Sterling (£), which is the Company's functional and presentation currency.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the Company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources.

The estimates and associated assumptions are based on historical experience and other factors considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of revision and future periods if the revision affects both current and future periods.

The following are the critical judgements and key sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year:

Useful economic lives of tangible fixed assets - The annual depreciation charge depends on the estimated useful lives of assets. The directors review these estimates regularly based on the current condition of the assets and expected future use.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover represents amounts receivable for services provided during the year. Revenue is recognised as the service is performed, based on the stage of completion or when the service has been completed, depending on the nature of the engagement.

All turnover is derived from customers based in the United Kingdom.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - 15% on reducing balance

Prident Dental Laboratory Limited (Registered number: 10404648)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2026

2. ACCOUNTING POLICIES - continued

Financial instruments
The Company has elected to apply the provisions of Section 11 'Basic Financial Instruments'.
Financial instruments are recognised in the Company's balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are initially measured at transaction price (including transaction costs) and subsequently measured at amortised cost using the effective interest method, less any impairment.

Basic financial liabilities
Short-term creditors are measured at transaction price. Other financial liabilities, including bank loans and other loans, are initially measured at transaction price (including transaction costs) and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash & cash equivalents
Cash comprises cash in hand and demand deposits. Cash equivalents are short-term, highly liquid investments that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value.

Cash and cash equivalents consist solely of balances held in the Company's bank current account. The Company does not hold any short-term investments and does not operate an overdraft facility.

Going concern
The financial statements have been prepared on a going concern basis. The directors have considered the Company's financial position and are satisfied that it has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2025 - 1 ) .

Prident Dental Laboratory Limited (Registered number: 10404648)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2026

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st April 2025
and 31st March 2026 13,655 3,916 17,571
DEPRECIATION
At 1st April 2025 7,169 1,660 8,829
Charge for year 973 339 1,312
At 31st March 2026 8,142 1,999 10,141
NET BOOK VALUE
At 31st March 2026 5,513 1,917 7,430
At 31st March 2025 6,486 2,256 8,742

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Trade debtors 14,419 8,044

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Bank loans and overdrafts 845 4,976
Tax 7,147 4,601
Social security and other taxes 77 139
Directors' current accounts 13 78
Accrued expenses 1,530 1,458
9,612 11,252

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.3.26 31.3.25
£    £   
Bank loans - 1-2 years - 844

8. LEASING AGREEMENTS
The Company had no material commitments under non-cancellable operating leases at the balance sheet date.

9. SECURED DEBTS

The Company had no secured liabilities at the balance sheet date.

Prident Dental Laboratory Limited (Registered number: 10404648)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2026

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.26 31.3.25
value: £    £   
50 Ordinary A £1 50 50
50 Ordinary B £1 50 50
100 100

11. RESERVES
Retained
earnings
£   

At 1st April 2025 29,737
Profit for the year 29,407
Dividends (25,400 )
At 31st March 2026 33,744

12. CONTINGENT LIABILITIES

The Company had no contingent liabilities at the balance sheet date.

13. RELATED PARTY DISCLOSURES

During the year, total dividends of £25,400 were paid to the director .

At the balance sheet date, amounts due to directors of £12 (2025: £78) were included within creditors.
These balances are unsecured, interest-free and repayable on demand.

14. POST BALANCE SHEET EVENTS

There have been no events after the balance sheet date affecting the Company since the financial period.